ArticleAdvances in therapy2024
Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing.
Lidan Yi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.